Droplet Microactuator Surface Modification for Nucleic Acid Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current PCR-based DNA amplification methods are labor-intensive, costly, and prone to cross-contamination, and they lack sensitivity and cost-effective quantification for pathogen detection. Additionally, existing nucleic acid sequencing technologies are expensive and not suitable for high-throughput, point-of-sample collection testing.

Innovation Solution

The development of a droplet-based microfluidic system that uses a droplet microactuator to perform surface modification and washing, enabling efficient nucleic acid amplification, sequencing, and immunoassays. This system allows for the manipulation of discrete droplets containing beads and reagents, facilitating precise control over biochemical reactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If PCR-based DNA amplification methods are used, then nucleic acid amplification can be achieved, but the process becomes labor-intensive and costly

Engineering Contradiction:
Improveamplification speedVSAvoidlabor intensity
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The patent divides the amplification process into discrete droplets, each containing individual or small groups of cells. This segmentation allows parallel processing of multiple samples simultaneously, increasing productivity while reducing manual labor through automated droplet manipulation and processing

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The droplet-based system enables self-contained biochemical reactions where each droplet acts as an independent reaction chamber. The system automatically performs mixing, heating, and detection without requiring manual intervention, thereby reducing labor intensity while maintaining amplification efficiency

Inventive Principle:
Principle #25Self-service

2Reliability

If conventional PCR methods are used, then DNA amplification can be performed, but cross-contamination occurs and sensitivity is insufficient

Engineering Contradiction:
Improvedetection sensitivityVSAvoidcross-contamination
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

By isolating each sample into separate droplets, the system physically prevents cross-contamination between different samples. Each droplet serves as an isolated reaction chamber, ensuring that nucleic acid amplification occurs without contamination from other samples while maintaining high detection sensitivity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The droplet acts as an intermediary barrier between samples and the environment. This intermediate structure protects against cross-contamination while allowing controlled access for reagents and detection methods, thereby improving reliability without introducing harmful factors

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If nucleic acid sequencing technologies are used, then sequencing can be performed, but the cost is high and throughput is limited

Engineering Contradiction:
Improvesequencing throughputVSAvoidreagent consumption
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The system segments sequencing reactions into individual droplets, each containing minimal required reagents. This allows parallel sequencing of multiple samples simultaneously, dramatically increasing throughput while reducing total reagent consumption through precise control of reagent distribution

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent optimizes reagent concentrations and reaction conditions at the droplet scale, changing parameters such as reagent dosage and reaction volume to achieve cost-effective sequencing. This parameter optimization enables high-throughput processing while minimizing reagent consumption compared to conventional bulk methods

Inventive Principle:
Principle #35Parameter changes

4Loss of time

If point-of-sample collection testing is implemented, then rapid diagnosis is achieved, but existing technologies lack sensitivity and cost-effectiveness

Engineering Contradiction:
Improvediagnosis timeVSAvoiddetection sensitivity
Core Design Contradiction:
Loss of timeVSReliability

Solution Approach 1:

The droplet-based system enables rapid processing of small sample volumes by dividing them into discrete droplets for parallel analysis. This segmentation allows quick detection of multiple analytes simultaneously, reducing diagnosis time while maintaining high sensitivity through optimized detection in each droplet

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces complex mechanical laboratory equipment with integrated microfluidic droplet manipulation systems that can be deployed at point-of-collection sites. This substitution enables rapid, sensitive detection without requiring extensive infrastructure, achieving both speed and reliability for portable testing

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS12332205B2Droplet-based surface modification and washing
Publication Date: 2025.06.17 ADVANCED LIQUID LOGIC INC
  • US12332205B2 patent drawing
  • US12332205B2 patent drawing
  • US12332205B2 patent drawing

AI summary

The present invention relates to droplet-based surface modification and washing. According to one embodiment, a method of splitting a droplet is provided, the method including providing a droplet microactuator including a droplet including one or more beads and immobilizing at least one of the one or more beads. The method further includes conducting one or more droplet operations to divide the droplet to yield a set of droplets including a droplet including the one or more immobilized beads and a droplet substantially lacking the one or more immobilized beads.